Differences in prognosis by p53 expression after neoadjuvant chemotherapy in triple-negative breast cancer.

Soo Youn Bae Jeong Hyeon LeeJeoung Won BaeSeung-Pil Jung

Published in: Annals of surgical treatment and research (2020)

Immunohistochemically detected p53 expression in TNBC could not predict the response to neoadjuvant chemotherapy. However, p53(+) TNBC had a better OS than p53(-) TNBC in patients who underwent neoadjuvant chemotherapy.

Keyphrases

neoadjuvant chemotherapy
locally advanced
lymph node
poor prognosis
sentinel lymph node
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
rectal cancer
squamous cell carcinoma
peritoneal dialysis
binding protein
prognostic factors
radiation therapy
long non coding rna
early stage